Cargando…

The end of the line? A case of drug resistance to third-line antiretroviral therapy

HIV drug resistance has been described in all antiretroviral drug classes and threatens the long-term success of HIV treatment. Here, we describe the first reported case of acquired resistance to the integrase strand transfer inhibitors in South Africa. This case illustrates the dilemma of treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rossouw, Theresa M., Hitchcock, Sonia, Botes, Mariëtte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AOSIS 2016
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843205/ https://www.ncbi.nlm.nih.gov/pubmed/29568612 http://dx.doi.org/10.4102/sajhivmed.v17i1.454

Ejemplares similares

Third-Line Antiretroviral Therapy: What Do We Do When the Appropriate Formulations Are Not Available?
por: Frigati, Lisa Jane, et al.
Publicado: (2022)

From antiretroviral therapy access to provision of third line regimens: evidence of HIV Drug resistance mutations to first and second line regimens among Ugandan adults
por: Namakoola, Ivan, et al.
Publicado: (2016)

Use of Third Line Antiretroviral Therapy in Latin America
por: Cesar, Carina, et al.
Publicado: (2014)

Case report: Emergence of dolutegravir resistance in a patient on second-line antiretroviral therapy
por: Mahomed, Kairoonisha, et al.
Publicado: (2020)

Rapid emergence of resistance to antiretroviral treatment after undisclosed prior exposure: A case report
por: Rossouw, Theresa M., et al.
Publicado: (2019)

Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, India
por: Khan, Samsuddin, et al.
Publicado: (2014)

Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa
por: Onoya, Dorina, et al.
Publicado: (2017)

Delays in third-line antiretroviral therapy and outcomes in North West province
por: Majova, Babalwa, et al.
Publicado: (2022)

HIV-1 Drug Resistance and Third-Line Therapy Outcomes in Patients Failing Second-Line Therapy in Zimbabwe
por: Chimbetete, Cleophas, et al.
Publicado: (2018)

Zimbabwe’s national third-line antiretroviral therapy program: Cohort description and treatment outcomes
por: Chimbetete, Cleophas, et al.
Publicado: (2020)

Estimating qualification and factors associated with third-line antiretroviral therapy referral in the Western Cape
por: Sheik, Sadiyya, et al.
Publicado: (2021)

Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance
por: Inzaule, Seth C., et al.
Publicado: (2018)

It is time to consider third-line options in antiretroviral-experienced paediatric patients?
por: van Zyl, Gert U, et al.
Publicado: (2011)

Third-line antiretroviral therapy in Africa: effectiveness in a Southern African retrospective cohort study
por: Meintjes, Graeme, et al.
Publicado: (2015)

HIV-1 genotypic profiling ensures effective response to third-line antiretroviral therapy in Cameroon
por: Mbouyap, Pretty Rosereine, et al.
Publicado: (2023)

Efficacy of third-line therapy using bevacizumab in a patient with metastatic colorectal cancer
por: Gaulin, J., et al.
Publicado: (2009)

Immunotherapy “Shock” with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinoma
por: Zarogoulidis, Paul, et al.
Publicado: (2017)

Association of First-Line and Second-Line Antiretroviral Therapy Adherence
por: Ramadhani, Habib O., et al.
Publicado: (2014)

Third-Line Antiretroviral Therapy Program in the South African Public Sector: Cohort Description and Virological Outcomes
por: Moorhouse, Michelle, et al.
Publicado: (2019)

HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in Uganda
por: Kityo, Cissy, et al.
Publicado: (2016)

First-line antiretroviral drug discontinuations in children
por: Fortuin-de Smidt, Melony, et al.
Publicado: (2017)

Symptomatic cerebrospinal fluid HIV-1 escape in two patients on second-line antiretroviral therapy in Uganda
por: Ssebambulidde, Kenneth, et al.
Publicado: (2019)

Clinically Relevant Transmitted Drug Resistance to First Line Antiretroviral Drugs and Implications for Recommendations
por: Monge, Susana, et al.
Publicado: (2014)

Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options
por: Meloni, Seema T, et al.
Publicado: (2017)

Simultaneous Occurrence of Nephrolithiasis, Fanconi Syndrome, and Nephro-osteopathy in a Patient on First-line Antiretroviral Therapy – A Case Report
por: Mangal, Vishal, et al.
Publicado: (2022)

Treatment Effect and Drug-Resistant Mutations in Chinese AIDS Patients Switching to Second-Line Antiretroviral Therapy
por: Zhang, Min, et al.
Publicado: (2014)

High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in Namibia
por: Jordan, Michael R., et al.
Publicado: (2020)

Evaluation of Adverse Drug Reaction Profile of Drugs Used as First-Line Antiretroviral Therapy
por: Chowta, Mukta N., et al.
Publicado: (2018)

Response to second line antiretroviral therapy in India
por: Singh, Anup, et al.
Publicado: (2012)

High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lomé, Togo
por: Dagnra, Anoumou Y, et al.
Publicado: (2011)

Antiretroviral resistance in HIV-infected Saudi children failing first-line highly active antiretroviral therapy
por: Al Hajjar, Sami Hussain, et al.
Publicado: (2012)

Interactions of HIV and Antiretroviral Therapy With Neutrophils and Platelets
por: Madzime, Morris, et al.
Publicado: (2021)

Emergent Resistance to Dolutegravir Among INSTI-Naïve Patients on First-line or Second-line Antiretroviral Therapy: A Review of Published Cases
por: Cevik, Muge, et al.
Publicado: (2020)

Frequency of resistance to first-line antiretroviral therapy observed among HIV patients
por: Khan, Feroz, et al.
Publicado: (2022)

HIV-1 Disease Progression and Drug Resistance Mutations among Children on First-Line Antiretroviral Therapy in Ethiopia
por: Getaneh, Yimam, et al.
Publicado: (2023)

Synchronous and metachronous malignant melanomas arising in a human immunodeficiency virus-positive patient after the commencement of highly active antiretroviral therapy treatment: a case report
por: Paul, Sharad P., et al.
Publicado: (2021)

Emergence of Drug Resistance in Human Immunodeficiency Virus Type 1 Infected Patients from Pune, India, at the End of 12 Months of First Line Antiretroviral Therapy Initiation
por: Patil, Rajesh T., et al.
Publicado: (2014)

Treatment outcomes and HIV drug resistance of patients switching to second-line regimens after long-term first-line antiretroviral therapy: An observational cohort study
por: Cao, Pi, et al.
Publicado: (2018)

Cryptococcal meningitis and immune reconstitution inflammatory syndrome in a pediatric patient with HIV after switching to second line antiretroviral therapy: a case report
por: Otto, Ssegujja Boniface Joseph, et al.
Publicado: (2020)

Factors Associated with the Development of Drug Resistance Mutations in HIV-1 Infected Children Failing Protease Inhibitor-Based Antiretroviral Therapy in South Africa
por: Rossouw, Theresa M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_g91a1ucqn9775brsc5vd8uftuq